4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine, 95.0%, 5g

2-(tert-Butyl(2-((di-tert-butylphosphino)methyl)benzyl)phosphino)pyridine, 97%, 50mg

2-Amino-3,5-dibromo-6-fluorobenzonitrile, 99.0%, 1g

Flacon à col étroit marron, 250 ml, 12 pièce(s)

2-Bromo-3-iodo-5-(trifluoromethyl)pyridine, 95.0%, 10g

4-aminobenzonitrile, min 98 %, pour la synthèse, 10 g, emballage plastique.

N~1~-(2,5-difluorophenyl)glycinamide hydrochloride, 95.0%, 10g

3-(4-Methylpiperazin-1-yl)pyridin-2-amine, 1g

N-4-Boc-N-1-Fmoc-2-Piperazine carboxylic acid, 95.0%, 10g

4-((7-Chloroquinolin-4-yl)amino)phenol, 96%, 100mg

Anthracen-9,10-bis(methyl-phosphonic acid diethylester), 97.0%, 1g

6-((3-Chloropropyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, 95.0%, 100g

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-tert-butyl-D-tyrosine>98.0%(HPLC)(T)1g